Medication Adherence Letter
Medication Therapy Management Program
April 11, 2013
Welcome to the Medication Adherence Program (MAP) for chronic conditions provided by AlaskaCare Health Plan. The Personalized Adherence Report is for your informational purposes only and will not affect your benefits in any way.
We are aware many of you take your medication exactly as prescribed. We applaud you for being so diligent. However, there are some members who, for a variety of reasons, aren’t quite as thorough as others. The goal of the Medication Adherence Program is to provide feedback to all members, who have certain conditions to help improve overall adherence and health outcomes for all.
It is common for adherence to decline over time in those who are taking long-term medication therapies for these chronic medical conditions. We hope to heighten the awareness of this fact and reverse this trend in order to improve the health and welfare of health plan members.
As part of this program, we are providing you a Personalized Adherence Report on the next page. This report measures your adherence to the medications you take that treat any of the following chronic conditions: diabetes, hypertension (high blood pressure), high cholesterol, and/or osteoporosis. Adherence is measured by the Portion of Days Covered (PDC) ratio. This ratio tells you the number of days of medication you have received over time. The PDC will be shown as a percentage from 0% to 100%. For example, a PDC of 50% means you have received 50% of the medication as prescribed by your physician over a specific period of time. A measurement of 80% or better is usually considered "adherent." A graph will show your adherence rate for each medication included in the program. Each bar on the graph stands for one of your medications and an average. The red line marks the level that is considered adherent. This chart reflects the adherence to your medications from 1/1/2013 to 4/6/2013.
Since the PDC is based on when prescriptions are filled, filling a prescription early or late affects the PDC. See the "Notes on Adherence" section at the end of this letter for some clarifying examples.
Should you have any questions about this report or do not wish to have this information sent to you, please call the EnvisionRxOption’s Medication Therapy Management Program at (866) 342-2183. TTY uses may call 711. They are available Monday through Friday from 8 a.m. to 5 p.m. PT. Please ask to speak with someone in the clinical department regarding information in this report.
AlaskaCare Health Plans